| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.9B | $2.8B | $2.8B | $0.7B | $5.1B | $1.4B | $0.8B | $0.8B |
| Cost of Revenue | — | — | — | — | — | — | — | $1.4B |
| Gross Profit | — | — | — | $0.4B | — | $0.8B | $0.4B | $0.4B |
| R&D Expense | $0.2B | $0.2B | $0.2B | $0.2B | $0.3B | $0.2B | $0.2B | $0.2B |
| SG&A Expense | $1.0B | $1.0B | $1.0B | $1.0B | $1.2B | $0.9B | $0.8B | $0.8B |
| Operating Income | $0.4B | $0.3B | $0.3B | $0.1B | $1.3B | $0.5B | $0.1B | $0.1B |
| Net Income | $0.2B | $0.3B | $0.7B | $0.1B | $0.9B | $0.4B | $0.1B | $0.1B |
| EPS (Basic) | $2.07 | $2.21 | $5.56 | $1.01 | $8.12 | $3.40 | $0.58 | $0.64 |
| EPS (Diluted) | $2.07 | $2.20 | $5.55 | $1.01 | $8.08 | $3.38 | $0.58 | $0.64 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.2B | $12.4B | $13.6B | $14.1B | $15.0B | $8.0B | $6.5B | $6.0B |
| Current Assets | $2.2B | $2.3B | $3.0B | $3.3B | $2.4B | $2.2B | $1.4B | $1.2B |
| Cash & Equivalents | $0.9B | $1.2B | $0.9B | $0.5B | $0.6B | $0.4B | $0.2B | $0.2B |
| Total Liabilities | $4.9B | $4.7B | $5.7B | $6.7B | $7.9B | $4.2B | $3.7B | $3.4B |
| Current Liabilities | $1.3B | $0.7B | $1.5B | $1.5B | $1.2B | $1.7B | $0.8B | $0.8B |
| Stockholders' Equity | $7.3B | $7.7B | $7.9B | $7.4B | $7.1B | $3.7B | $2.8B | $2.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.6B | $0.1B | $0.7B | $1.4B | $0.9B | $0.4B | $0.3B |
| Investing Cash Flow | $-0.0B | $0.8B | $1.3B | $-0.1B | $-4.1B | $-0.5B | $-0.5B | $-0.2B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.9B | $-1.1B | $-0.9B | $-0.7B | $-2.9B | $-0.2B | $0.2B | $-0.2B |